2021-004849-20: A Study to Assess the Safety of BIIB122 Tablets and if it can Slow the Worsening of Early-Stage Parkinson’s Disease in Participants Between the Ages of 30 and 80 |
|
|
| Not yet recruiting | 2 | 640 | Europe | BIIB122, DNL151, DN0001575, DN1575, Tablet | Biogen Idec Research Limited, BIOGEN IDEC RESEARCH LIMITED, Biogen Idec Research Limited | Parkinson's Disease, Parkinson's Disease, Diseases [C] - Nervous System Diseases [C10] | | | | |
LUMA, NCT05348785: A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80 |
|
|
| Recruiting | 2 | 640 | Europe, Canada, Japan, US, RoW | BIIB122, DNL151, BIIB122-Matching Placebo | Biogen, Denali Therapeutics Inc. | Parkinson Disease | 12/25 | 12/25 | | |
